Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M312525200 on January 21, 2004

J. Biol. Chem., Vol. 279, Issue 15, 15314-15322, April 9, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/15/15314    most recent
M312525200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimoaka, T.
Right arrow Articles by Kawaguchi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimoaka, T.
Right arrow Articles by Kawaguchi, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Impairment of Bone Healing by Insulin Receptor Substrate-1 Deficiency*

Takashi Shimoaka{ddagger}, Satoru Kamekura{ddagger}, Hirotaka Chikuda§, Kazuto Hoshi§, Ung-il Chung§, Toru Akune{ddagger}, Zenjiro Maruyama¶, Toshihisa Komori¶, Michihiro Matsumoto||, Wataru Ogawa||, Yasuo Terauchi**, Takashi Kadowaki**, Kozo Nakamura{ddagger}, and Hiroshi Kawaguchi{ddagger}{ddagger}{ddagger}

From the Departments of {ddagger}Orthopaedic Surgery, §Tissue Engineering, and **Metabolic Diseases, Faculty of Medicine, University of Tokyo, Hongo, Bunkyo, Tokyo 113-8655, Department of Molecular Medicine, Osaka University Medical School, Suita, Osaka 565-0871, and ||Division of Diabetes, Digestive and Kidney Diseases, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan

Insulin receptor substrate-1 (IRS-1) is an essential molecule for intracellular signaling of insulin-like growth factor (IGF)-I and insulin, both of which are potent anabolic regulators of bone and cartilage metabolism. To investigate the role of IRS-1 in bone regeneration, fracture was introduced in the tibia, and its healing was compared between wild-type (WT) mice and mice lacking the IRS-1 gene (IRS-1-/- mice). Among 15 IRS-1-/- mice, 12 remained in a non-union state even at 10 weeks after the operation, whereas all 15 WT mice showed a rigid bone union at 3 weeks. This impairment was because of the suppression of callus formation with a decrease in chondrocyte proliferation and increases in hypertrophic differentiation and apoptosis. Reintroduction of IRS-1 to the IRS-1-/- fractured site using an adenovirus vector significantly restored the callus formation. In the culture of chondrocytes isolated from the mouse growth plate, IRS-1-/- chondrocytes showed less mitogenic ability and Akt phosphorylation than WT chondrocytes. An Akt inhibitor decreased the IGF-I-stimulated DNA synthesis of chondrocytes more potently in the WT culture than in the IRS-1-/- culture. We therefore conclude that IRS-1 deficiency impairs bone healing at least partly by inhibiting chondrocyte proliferation through the phosphatidylinositol 3-kinase/Akt pathway, and we propose that IRS-1 can be a target molecule for bone regenerative medicine.


Received for publication, November 16, 2003 , and in revised form, January 15, 2004.

* This work was supported by Grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology 11470301 and 12137201, the Uehara Memorial Foundation, and the Takeda Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger}{ddagger} To whom correspondence should be addressed: Dept. of Orthopaedic Surgery, Faculty of Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo, Tokyo 113-8655, Japan. Tel.: 81-3-3815-5411 (ext. 30473 or 33376); Fax: 81-3-3818-4082; E-mail: kawaguchi-ort{at}h.u-tokyo.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Shinoda, N. Ogata, A. Higashikawa, I. Manabe, T. Shindo, T. Yamada, F. Kugimiya, T. Ikeda, N. Kawamura, Y. Kawasaki, et al.
Kruppel-like Factor 5 Causes Cartilage Degradation through Transactivation of Matrix Metalloproteinase 9
J. Biol. Chem., September 5, 2008; 283(36): 24682 - 24689.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Orthop SurgHome page
S. B. Chaudhary, F. A. Liporace, A. Gandhi, B. G. Donley, M. S. Pinzur, and S. S. Lin
Complications of Ankle Fracture in Patients With Diabetes
J. Am. Acad. Ortho. Surg., March 1, 2008; 16(3): 159 - 170.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Perrini, A. Natalicchio, L. Laviola, A. Cignarelli, M. Melchiorre, F. De Stefano, C. Caccioppoli, A. Leonardini, S. Martemucci, G. Belsanti, et al.
Abnormalities of Insulin-Like Growth Factor-I Signaling and Impaired Cell Proliferation in Osteoblasts from Subjects with Osteoporosis
Endocrinology, March 1, 2008; 149(3): 1302 - 1313.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. N. Athanasopoulos, D. Schneider, T. Keiper, V. Alt, U. R. Pendurthi, U. M. Liegibel, U. Sommer, P. P. Nawroth, C. Kasperk, and T. Chavakis
Vascular Endothelial Growth Factor (VEGF)-induced Up-regulation of CCN1 in Osteoblasts Mediates Proangiogenic Activities in Endothelial Cells and Promotes Fracture Healing
J. Biol. Chem., September 14, 2007; 282(37): 26746 - 26753.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
B. S Miller, J. T Bronk, T. Nishiyama, H. Yamagiwa, A. Srivastava, M. E Bolander, and C. A Conover
Pregnancy associated plasma protein-A is necessary for expeditious fracture healing in mice
J. Endocrinol., March 1, 2007; 192(3): 505 - 513.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. M. Thrailkill, C. K. Lumpkin Jr., R. C. Bunn, S. F. Kemp, and J. L. Fowlkes
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E735 - E745.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Kugimiya, H. Kawaguchi, S. Kamekura, H. Chikuda, S. Ohba, F. Yano, N. Ogata, T. Katagiri, Y. Harada, Y. Azuma, et al.
Involvement of Endogenous Bone Morphogenetic Protein (BMP) 2 and BMP6 in Bone Formation
J. Biol. Chem., October 21, 2005; 280(42): 35704 - 35712.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Yamaguchi, N. Ogata, Y. Shinoda, T. Akune, S. Kamekura, Y. Terauchi, T. Kadowaki, K. Hoshi, U.-I. Chung, K. Nakamura, et al.
Insulin Receptor Substrate-1 Is Required for Bone Anabolic Function of Parathyroid Hormone in Mice
Endocrinology, June 1, 2005; 146(6): 2620 - 2628.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H. Chikuda, F. Kugimiya, K. Hoshi, T. Ikeda, T. Ogasawara, T. Shimoaka, H. Kawano, S. Kamekura, A. Tsuchida, N. Yokoi, et al.
Cyclic GMP-dependent protein kinase II is a molecular switch from proliferation to hypertrophic differentiation of chondrocytes
Genes & Dev., October 1, 2004; 18(19): 2418 - 2429.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement